Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

NCT00182767 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Fallopian Tube Cancer
Female Reproductive Cancer
Recurrent Breast Cancer
Recurrent Ovarian Epithelial Cancer
Stage III Ovarian Epithelial Cancer
Stage IV Breast Cancer
Stage IV Ovarian Epithelial Cancer

Interventions

DRUG: ixabepilone
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

National Cancer Institute (NCI)